Griffin Asset Management’s AstraZeneca AZN Stock Holding History

Griffin Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,631	Closed	-$508K	–	226
2020 Q3	$508K	Buy	4,631 +67	+1%	+$7.45K	0.08%	151
2020 Q2	$483K	Buy	4,564 +1,000	+28%	+$103K	0.08%	153
2020 Q1	$318K	Sell	3,564 -23	-0.6%	-$2.17K	0.06%	161
2019 Q4	$358K	Hold	3,587	–	–	0.05%	173
2019 Q3	$320K	Sell	3,587 -244	-6%	-$21.2K	0.05%	180
2019 Q2	$316K	Sell	3,831 -1,232	-24%	-$96.6K	0.04%	209
2019 Q1	$409K	Sell	5,063 -1,500	-23%	-$118K	0.06%	184
2018 Q4	$498K	Hold	6,563	–	–	0.08%	167
2018 Q3	$519K	Buy	+6,563	New	+$496K	0.08%	177

Other funds holding AZN

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Griffin Asset Management's AZN Position: Q4 2020 in Review

Griffin Asset Management sold out of AstraZeneca (AZN) in Q4 2020, closing a stake of 4,631 shares — an estimated $508K sold.

Griffin Asset Management first reported a position in AZN in Q3 2018 and held it in 9 quarters. The position peaked at $519K in Q3 2018. 787 funds tracked by Wall St. Rank hold AZN as of Q4 2020.

Griffin Asset Management reported no remaining AstraZeneca position as of Q4 2020 after selling out during the quarter.
Griffin Asset Management sold 4,631 AstraZeneca shares in Q4 2020, an estimated $508K.
Griffin Asset Management first reported a position in AstraZeneca in Q3 2018 and held it in 9 quarters.
Griffin Asset Management's AstraZeneca position peaked at $519K in Q3 2018.
787 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2020.

Based on Griffin Asset Management's 13F filing for Q4 2020, filed 27 Jan 2021.